MIRA INFORM REPORT
|
Report Date : |
03.12.2014 |
IDENTIFICATION DETAILS
|
Name : |
ATHENA DRUG DELIVERY SOLUTIONS PRIVATE LIMITED (w.e.f. 07.04.2011) |
|
|
|
|
Formerly Known
As : |
ETHYPHARM LL PRIVATE LIMITED [w.e.f.30.06.2000] LLOYDS LABORATORIES PRIVATE LIMITED [w.e.f.16.11.1998] LLOYDS LABORATORIES LIMITED |
|
|
|
|
Registered
Office : |
602, 6th
Floor, Tower – II, ‘Star Hub’, International Airport Road, Sahar, Andheri
(East), Mumbai – 400059, Maharashtra |
|
|
|
|
Country : |
India |
|
|
|
|
Financials (as
on) : |
31.12.2013 |
|
|
|
|
Date of
Incorporation : |
16.11.1995 |
|
|
|
|
Com. Reg. No.: |
11-094546 |
|
|
|
|
Capital
Investment / Paid-up Capital : |
Rs. 223.315
Millions |
|
|
|
|
CIN No.: [Company Identification
No.] |
U24230MH1995PTC094546 |
|
|
|
|
PAN No.: [Permanent Account No.] |
AAACE9894R |
|
|
|
|
Legal Form : |
Private Limited Liability Company |
|
|
|
|
Legal Form : |
Private Limited Liability Company |
|
|
|
|
Line of Business
: |
Manufacturer and Exporter pharmaceutical products. |
|
|
|
|
No. of Employees
: |
130 (Approximately) |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba (42) |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
USD 770000 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Slow but correct |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is an established company having satisfactory track record. The company has processes above average financial performance which
led to wiping off its accumulated losses and achieved profitability from its
operation during 2013. Further rating also takes into consideration company’s
improved financial risk profile and decent capital base of the company. Trade relations are fair. Business is active. Payment terms are
reported to be slow but correct. The company can be considered for business dealings at usual trade
terms and condition. |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – June 1, 2014
|
Country Name |
Previous Rating (31.03.2014) |
Current Rating (01.06.2014) |
|
India |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
INDIAN ECONOMIC OVERVIEW
N E W S
Verdict Implications
: Apex court order may alter coal import dynamics. Traders go slow on talks
over coal supply contracts, uncertainty over cancellation of blocks weigh on stocks.
Recent arrest of the
Chennai head of the Registrar of Companies, the ministry of corporate affairs
arm that ensures that companies file all the information required by the
Companies Act is the latest manifestation of a messy fight between a father and
his adopted son for the control of Rs 40000 mn business empire. The Central
Bureau of Investigation arrested Manumeethi Cholan after he accepted Rs 10
lakhs as bribe from M A M Ramaswamy, a CBI official said.
Central Bureau of Investigation
books Electrotherm for cheating Central Bank of Rs 4360 mn.
Infosys maintains
revenue guidance. COO Rao says attrition still an area of concern and it would
take a few more quarters to bring down levels to 13-15 %.
DHL to invest
Euro 100 mn in India over next 2 years. The firm has chosen India to pilot its
e-commerce business model for the Asia-Pacific region.
Blackstone may buy
stake in BlueRidge SEZ in line with the fund’s real estate strategy in India.
Kingfisher Airlines
Ltd grounded in October 2012 under the weight of heavy debt and accumulated
losses, recently approached the Delhi high court for relief in two separate
cases. The airline challenged a notice by Punjab & National Bank alleging
that It had wilfully defaulted on Rs 7700 mn of loans and sought more time to
comply with the requirements under the listing agreements with the Stock
Exchanges.
OnMobile likely to
sack another 300 employees. The lay-offs follow a spate of senior-level exits
over the past two years, starting with of its founder. The overall lay-offs
could number around 600 and are driven by the need to cut costs, says a former
employee.
EXTERNAL AGENCY RATING
|
Rating Agency Name |
Not Available |
|
Rating |
Not Available |
|
Rating Explanation |
Not Available |
|
Date |
Not Available |
RBI DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available RBI Defaulters’ list.
EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of
31-03-2014.
INFORMATION PARTED BY (GENERAL DETAILS)
|
Name : |
Mr. Subhash Nair |
|
Designation : |
Finance Head |
|
Contact No.: |
91-22-67370700 |
|
Date : |
03.12.2014 |
LOCATIONS
|
Registered Office : |
602, 6th
Floor, Tower – II, ‘Star Hub’, International Airport Road, Sahar, Andheri
(East), Mumbai – 400059, Maharashtra, India |
|
Tel. No.: |
91-22-67370700 |
|
Fax No.: |
91-22-67370701 |
|
E-Mail : |
|
|
Website : |
|
|
|
|
|
Head Office : |
Athena
Pharmaceutiques SAS 106, Bureaux de la Colline Bat F2, 92213 Saint Cloud, France |
|
|
|
|
Manufacturing Site and R&D Center : |
A1-A5, MIDC, Chemical Zone, Near Ion Exchange Company, Ambernath
[West] – 421501, India |
|
Tel. No.: |
91-251-3984400 |
|
Fax No.: |
91-251-3984444 |
DIRECTORS
As on 21.03.2014
|
Name : |
Alexandre Luc Williams |
|
Designation : |
Director |
|
Address : |
21, Avenue Mozart, 75016, Paris 16, France |
|
Date of Birth/Age : |
31.07.1968 |
|
Date of Appointment : |
08.03.2011 |
|
DIN No.: |
03451876 |
|
|
|
|
Name : |
Pierre Behinam |
|
Designation : |
Director |
|
Address : |
Flat No. 2, Ground Floor, American View, Oomer Park, Bhulabhai Desai
Road, Mumbai – 400026, Maharashtra, India |
|
Date of Birth/Age : |
18.01.1968 |
|
Date of Appointment : |
08.03.2011 |
|
DIN No.: |
03451907 |
|
|
|
|
Name : |
Jean Jacques Bancel |
|
Designation : |
Nominee Director |
|
Address : |
35, Rue Henri Regnault, 92.500 Rueil Malmansion, France |
|
Date of Birth/Age : |
22.07.1968 |
|
Date of Appointment : |
08.04.2011 |
|
DIN No.: |
03497091 |
KEY EXECUTIVES
|
Name : |
Mr. Subhash Nair |
|
Designation : |
Finance Head |
MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN
As on 21.03.2014
|
Names of Shareholders |
|
No. of Shares |
|
Alexandre Luc Williams |
|
2 |
|
Athena Pharmaceutiques, France |
|
22331506 |
|
Total |
|
22331508 |
Equity Share Break up (Percentage of Total Equity)
As on 21.03.2014
|
Category |
Percentage |
|
Foreign holdings( Foreign institutional
investor(s), Foreign companie(s) Foreign financial institution(s),
Non-resident Indian(s) or Overseas Corporate bodies or Others |
100.00 |
|
Total |
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Manufacturer and Exporter pharmaceutical products. |
||||
|
|
|
||||
|
Products : |
|
||||
|
|
|
||||
|
Brand Names : |
Not Divulged |
||||
|
|
|
||||
|
Agencies Held : |
Not Divulged |
||||
|
|
|
||||
|
Exports : |
|
||||
|
Products : |
Finished Goods |
||||
|
Countries : |
|
||||
|
|
|
||||
|
Imports : |
|
||||
|
Products : |
Raw Material |
||||
|
Countries : |
China |
||||
|
|
|
||||
|
Terms : |
|
||||
|
Selling : |
L/C, Cash and Credit |
||||
|
|
|
||||
|
Purchasing : |
L/C, Cash and Credit |
PRODUCTION STATUS (AS ON 31.12.2013)
|
Particulars |
Unit |
Installed
Capacity* [Qty] |
Actual
Production [Qty] |
|
Pellets and granules |
Kg |
159,000 |
23,417 |
|
Tablets |
Units |
432,000,000 |
28,991,136 |
|
Capsules |
Units |
170,000,000 |
4,349,830 |
|
Sachets |
Units |
4,200,000 |
2,390,750 |
Note:
* Installed capacity is as certified by the Management and accepted by the
Auditors, as it is a technical matter.
GENERAL INFORMATION
|
Suppliers : |
|
||||||||||||||||||||||
|
|
|
||||||||||||||||||||||
|
Customers : |
|
||||||||||||||||||||||
|
|
|
||||||||||||||||||||||
|
No. of Employees : |
130 (Approximately) |
||||||||||||||||||||||
|
|
|
||||||||||||||||||||||
|
Bankers : |
|
||||||||||||||||||||||
|
|
|
||||||||||||||||||||||
|
Facilities : |
|
|
|
|
|
Banking
Relations : |
|
|
|
|
|
Auditors : |
|
|
Name : |
SNH and Associates Chartered Accountants |
|
Address : |
A/203-207, Mangal Arambh, Off. S.V. Road, Near Kora
Kendra, Borivali (West), Mumbai – 400092, Maharashtra, India |
|
Income-tax
PAN of auditor or auditor's firm : |
ACAFS8638J |
|
|
|
|
Memberships : |
Not Available |
|
|
|
|
Collaborators : |
Not Available |
|
|
|
|
Holding Company : |
Athena Pharmaceutiques, France |
CAPITAL STRUCTURE
As on 31.12.2013
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
50750000 |
Equity Shares |
Rs.10/- each |
Rs. 507.500 Millions |
|
|
|
|
|
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
22331508 |
Equity Shares |
Rs.10/- each |
Rs. 223.315
Millions |
|
|
|
|
|
FINANCIAL DATA
[all figures are
in Rupees Millions]
ABRIDGED BALANCE
SHEET
|
SOURCES
OF FUNDS |
31.12.2013 |
31.12.2012 |
31.12.2011 |
|
|
|
|
|
|
I.
EQUITY AND LIABILITIES |
|
|
|
|
(1)Shareholders' Funds |
|
|
|
|
(a) Share Capital |
223.315 |
223.315 |
223.316 |
|
(b) Reserves & Surplus |
46.688 |
(45.775) |
(31.549) |
|
(c) Money received against
share warrants |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
(2) Share Application money
pending allotment |
0.000 |
0.000 |
0.000 |
|
Total
Shareholders’ Funds (1) + (2) |
270.003 |
177.540 |
191.767 |
|
|
|
|
|
|
(3) Non-Current Liabilities |
|
|
|
|
(a) long-term borrowings |
0.000 |
120.076 |
86.750 |
|
(b) Deferred tax liabilities
(Net) |
0.000 |
0.000 |
0.000 |
|
(c) Other long term
liabilities |
0.000 |
0.000 |
0.000 |
|
(d) long-term provisions |
2.203 |
4.109 |
5.081 |
|
Total
Non-current Liabilities (3) |
2.203 |
124.185 |
91.831 |
|
|
|
|
|
|
(4) Current Liabilities |
|
|
|
|
(a) Short term borrowings |
38.971 |
0.000 |
0.000 |
|
(b) Trade payables |
32.169 |
23.242 |
23.265 |
|
(c) Other current liabilities |
8.326 |
19.658 |
14.549 |
|
(d) Short-term provisions |
0.801 |
0.779 |
2.020 |
|
Total
Current Liabilities (4) |
80.267 |
43.679 |
39.834 |
|
|
|
|
|
|
TOTAL |
352.473 |
345.404 |
323.432 |
|
|
|
|
|
|
II.
ASSETS |
|
|
|
|
(1) Non-current assets |
|
|
|
|
(a) Fixed Assets |
|
|
|
|
(i) Tangible assets |
254.314 |
247.347 |
248.435 |
|
(ii) Intangible Assets |
3.546 |
0.514 |
0.925 |
|
(iii) Capital work-in-progress |
21.611 |
18.358 |
6.486 |
|
(iv) Intangible assets under
development |
0.000 |
0.000 |
0.000 |
|
(b) Non-current Investments |
0.001 |
0.001 |
0.001 |
|
(c) Deferred tax assets (net) |
0.000 |
0.000 |
0.000 |
|
(d) Long-term Loan and Advances |
10.689 |
12.996 |
9.444 |
|
(e) Other Non-current assets |
0.000 |
0.000 |
0.000 |
|
Total
Non-Current Assets |
290.161 |
279.216 |
265.291 |
|
|
|
|
|
|
(2) Current assets |
|
|
|
|
(a) Current investments |
0.000 |
0.000 |
0.000 |
|
(b) Inventories |
15.523 |
12.668 |
10.536 |
|
(c) Trade receivables |
40.890 |
40.674 |
23.698 |
|
(d) Cash and cash equivalents |
1.409 |
4.619 |
7.765 |
|
(e) Short-term loans and
advances |
4.490 |
8.226 |
16.140 |
|
(f) Other current assets |
0.000 |
0.001 |
0.002 |
|
Total
Current Assets |
62.312 |
66.188 |
58.141 |
|
|
|
|
|
|
TOTAL |
352.473 |
345.404 |
323.432 |
PROFIT & LOSS
ACCOUNT
|
|
PARTICULARS |
31.12.2013 |
31.12.2012 |
31.12.2011 |
|
|
SALES |
|
|
|
|
|
Turnover |
167.240 |
147.894 |
105.178 |
|
|
Income from License fee and Services |
35.420 |
20.824 |
28.130 |
|
|
TOTAL |
202.660 |
168.718 |
133.308 |
|
|
|
|
|
|
|
|
EXPENSES |
NA |
NA |
NA |
|
|
|
|
|
|
|
|
PROFIT/
(LOSS) BEFORE INTEREST, TAX,
DEPRECIATION AND AMORTISATION |
26.877 |
6.912 |
14.953 |
|
|
|
|
|
|
|
|
FINANCIAL
EXPENSES |
3.853 |
2.802 |
0.000 |
|
|
|
|
|
|
|
|
DEPRECIATION/
AMORTISATION |
17.194 |
16.266 |
15.592 |
|
|
|
|
|
|
|
|
Exceptional Items |
0.115 |
2.070 |
0.000 |
|
|
|
|
|
|
|
|
PROFIT/
(LOSS) BEFORE TAX |
5.713 |
(14.226) |
(0.640) |
|
|
|
|
||
|
|
TAX |
0.000 |
0.000 |
0.000 |
|
|
|
|
||
|
|
PROFIT/
(LOSS) AFTER TAX |
5.713 |
(14.226) |
(0.640) |
|
|
|
|
|
|
|
|
EARNINGS
IN FOREIGN CURRENCY |
|
|
|
|
|
F.O.B. Value of Exports |
101.390 |
75.885 |
54.183 |
|
|
Income from services rendered |
2.510 |
0.506 |
15.034 |
|
|
License fees received |
30.626 |
12.603 |
1.520 |
|
|
Export Commission |
0.000 |
0.000 |
0.913 |
|
|
Other Miscellaneous Income |
0.000 |
0.000 |
2.005 |
|
|
TOTAL
EARNINGS |
134.526 |
88.994 |
70.737 |
|
|
|
|
|
|
|
|
Earnings
/ (Loss) Per Share (Rs.) |
0.26 |
(0.64) |
(0.03) |
KEY RATIOS
|
PARTICULARS |
|
31.12.2013 |
31.12.2012 |
31.12.2011 |
|
Net Profit Margin (PAT / Sales) |
(%) |
3.42 |
(9.62) |
(0.61) |
|
|
|
|
|
|
|
Operating Profit Margin (PBIDT/Sales) |
(%) |
16.07 |
114.08 |
126.75 |
|
|
|
|
|
|
|
Return on Total Assets (PBT/Total Assets} |
(%) |
1.73 |
(4.35) |
(0.20) |
|
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
0.02 |
(0.08) |
0.00 |
|
|
|
|
|
|
|
Debt Equity Ratio (Total Debt /Networth) |
|
0.14 |
0.68 |
0.45 |
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
0.78 |
1.52 |
1.46 |
FINANCIAL ANALYSIS
[all figures are
in Rupees Millions]
DEBT EQUITY RATIO
|
Particular |
31.12.2011 |
31.12.2012 |
31.12.2013 |
|
|
(Rs.
In Millions) |
(Rs.
In Millions) |
(Rs.
In Millions) |
|
Share Capital |
223.316 |
223.315 |
223.315 |
|
Reserves & Surplus |
(31.549) |
(45.775) |
46.688 |
|
Net
worth |
191.767 |
177.540 |
270.003 |
|
|
|
|
|
|
long-term borrowings |
86.750 |
120.076 |
0.000 |
|
Short term borrowings |
0.000 |
0.000 |
38.971 |
|
Total
borrowings |
86.750 |
120.076 |
38.971 |
|
Debt/Equity
ratio |
0.452 |
0.676 |
0.144 |
YEAR-ON-YEAR GROWTH
|
Year
on Year Growth |
31.12.2011 |
31.12.2012 |
31.12.2013 |
|
|
(Rs.
In Millions) |
(Rs.
In Millions) |
(Rs.
In Millions) |
|
Turnover |
105.178 |
147.894 |
167.240 |
|
|
|
40.613 |
13.081 |
NET PROFIT MARGIN
|
Net
Profit Margin |
31.12.2011 |
31.12.2012 |
31.12.2013 |
|
|
(Rs.
In Millions) |
(Rs.
In Millions) |
(Rs.
In Millions) |
|
Turnover |
105.178 |
147.894 |
167.240 |
|
Profit |
(0.640) |
(14.226) |
5.713 |
|
|
(0.61%) |
(9.62%) |
3.42% |
LOCAL AGENCY FURTHER INFORMATION
|
Sr. No. |
Check List by Info Agents |
Available in
Report (Yes / No) |
|
1] |
Year of Establishment |
Yes |
|
2] |
Locality of the firm |
Yes |
|
3] |
Constitutions of the firm |
Yes |
|
4] |
Premises details |
No |
|
5] |
Type of Business |
Yes |
|
6] |
Line of Business |
Yes |
|
7] |
Promoter's background |
Yes |
|
8] |
No. of employees |
Yes |
|
9] |
Name of person contacted |
Yes |
|
10] |
Designation of contact
person |
Yes |
|
11] |
Turnover of firm for last
three years |
Yes |
|
12] |
Profitability for last
three years |
Yes |
|
13] |
Reasons for variation
<> 20% |
-- |
|
14] |
Estimation for coming
financial year |
No |
|
15] |
Capital in the business |
Yes |
|
16] |
Details of sister
concerns |
Yes |
|
17] |
Major suppliers |
Yes |
|
18] |
Major customers |
Yes |
|
19] |
Payments terms |
Yes |
|
20] |
Export / Import details
(if applicable) |
Yes |
|
21] |
Market information |
-- |
|
22] |
Litigations that the firm
/ promoter involved in |
-- |
|
23] |
Banking Details |
Yes |
|
24] |
Banking facility details |
Yes |
|
25] |
Conduct of the banking
account |
-- |
|
26] |
Buyer visit details |
-- |
|
27] |
Financials, if provided |
Yes |
|
28] |
Incorporation details, if
applicable |
Yes |
|
29] |
Last accounts filed at
ROC |
Yes |
|
30] |
Major Shareholders, if
available |
Yes |
|
31] |
Date of Birth of
Proprietor/Partner/Director, if available |
Yes |
|
32] |
PAN of Proprietor/Partner/Director,
if available |
No |
|
33] |
Voter ID No of
Proprietor/Partner/Director, if available |
No |
|
34] |
External Agency Rating,
if available |
No |
Note:
The registered office of the company has been shifted from Fortune 2000,
C-1, 2nd Floor, Bandra Kurla Complex, Bandra (East), Mumbai –
400051, Maharashtra, India to the present w.e.f.14.12.2012
OPERATIONS :
The year 2013 was a Path breaking year for the Company. The Company has posted a profit of 5.7Mn during the year and the plant of the company was approved by Health authorities of Greece and thus they can enter the market of Europe. They have been waiting for this certification since last four years and this will drive the company?s future Growth. As the Financials results stand, this was due to Management Strategies, focus on high Margin products, High value products, and Campaign production and last not the least the depreciation of Indian Rupee. During the year turnover has increased and the License fee which is the second most stream of the income has shown a good growth. This has happened by signing so many contracts by their Business team with the customers across the Globe by licensing the products in their respective territories which will eventually convert into sales in the longer period.
BACKGROUND
The Company was incorporated by Lloyd’s group as a Private Limited Company in 1995. During 1999-2000, the Company was taken over by Ethypharm group. During the year 2010-2011 there was a change in management control and it was taken over by Athena Pharmaceutiques a French based Company and it is a wholly owned subsidiary of Athena Pharmaceutiques, The Company is in the business of manufacturing pharmaceutical products. The Company also provides R&D services and Clinical Research services.
UNSECURED LOAN
|
PARTICULARS |
31.12.2013 (Rs.
in Millions) |
31.12.2012 (Rs.
in Millions) |
|
Long-term
Borrowings |
|
|
|
Term loans from others |
0.000 |
86.750 |
|
Total |
0.000 |
86.750 |
INDEX
OF CHARGES
|
S.NO. |
CHARGE ID |
DATE OF CHARGE
CREATION/MODIFICATION |
CHARGE AMOUNT
SECURED |
CHARGE HOLDER |
ADDRESS |
SERVICE REQUEST
NUMBER (SRN) |
|
1 |
10469182 |
10/12/2013 |
50,000,000.00 |
AXIS BANK LIMITED |
CORPROATE BANKING
BRANCH,AXIS HOUSE,GR FLOOR, BOM |
B93139095 |
|
2 |
10442267 |
31/07/2013 |
50,000,000.00 |
AXIS BANK LIMITED |
CORPROATE BANKING BRANCH,AXIS
HOUSE,GR FLOOR, BOM |
B81801417 |
FIXED ASSETS
Tangible assets
- Land
Buildings - Plant and equipment
- Furniture and fixtures
- Vehicles
- Office equipment
- Computer equipments
- Other equipments
Intangible assets
- Brands and trade marks
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist
organization or whom notice had been received that all financial transactions
involving their assets have been blocked or convicted, found guilty or against
whom a judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No exist to suggest that subject is or was
the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No available
information exist that suggest that subject or any of its principals have been
formally charged or convicted by a competent governmental authority for any
financial crime or under any formal investigation by a competent government
authority for any violation of anti-corruption laws or international anti-money
laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms and
conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.61.93 |
|
|
1 |
Rs.97.39 |
|
Euro |
1 |
Rs.77.21 |
INFORMATION DETAILS
|
Information Gathered
by : |
PRT |
|
|
|
|
Analysis Done by
: |
KAR |
|
|
|
|
Report Prepared
by : |
KVT |
SCORE & RATING EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
5 |
|
PAID-UP CAPITAL |
1~10 |
5 |
|
OPERATING SCALE |
1~10 |
5 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
5 |
|
--PROFITABILIRY |
1~10 |
5 |
|
--LIQUIDITY |
1~10 |
5 |
|
--LEVERAGE |
1~10 |
4 |
|
--RESERVES |
1~10 |
4 |
|
--CREDIT LINES |
1~10 |
4 |
|
--MARGINS |
-5~5 |
-- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
YES |
|
--AFFILIATION |
YES/NO |
YES |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
DEFAULTER |
|
|
|
--RBI |
YES/NO |
NO |
|
--EPF |
YES/NO |
NO |
|
TOTAL |
|
42 |
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is calculated
from a composite of weighted scores obtained from each of the major sections of
this report. The assessed factors and their relative weights (as indicated
through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment record
(10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.